Assistant Professor, Internal Medicine, University Kansas School of Medicine
Hematology
Dr. Omar S. Aljitawi, MD
|
|
Give Review
Omar Aljitawi works in the field of Hematology. He went to medical school at University of Kansas School of Medicine. He received 1 awards: "Regional Top Doctor". Dr. Omar S. Aljitawi is a published doctor. He has 26 papers published. The most current publication "Evaluation of cytomegalovirus reactivation and tolerability in seropositive umbilical cord transplant patients after implementation of an intensive prevention strategy." Omar S. Aljitawi, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- Evaluation of cytomegalovirus reactivation and tolerability in seropositive umbilical cord transplant patients after implementation of an intensive prevention strategy.
- Rates of complete diagnostic testing for patients with Acute myeloid leukemia.
- Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem Cell transplant patients with g...
- Ectodermal differentiation of Wharton's jelly mesenchymal stem Cells for tissue engineering and regenerative medicine applications.
- Routine radiographic screening after completion of initial chemotherapy and relapse-free survival after transplant in patients with relapsed Lymphoma.
- Phase IIa cross-over study of propylene glycol-free melphalan (LGD-353) and alkeran in multiple Myeloma autologous transplantation.
- Intestinal ischemia after allogeneic stem Cell transplantation: a report of four cases.
- Rituximab as a treatment for factor VIII inhibitor in a patient with Chronic GVHD.
- Pulmonary manifestations of the pre-enGraftment syndrome after umbilical cord blood transplantation.
- Preclinical and Phase I Results of Decitabine in Combination with Midostaurin (PKC412) for Newly Diagnosed Elderly or Relapsed/Refractory Adult Patients with Acute Mye...
- Combined use of multiday palonosetron with aprepitant and low-dose dexamethasone in prevention of nausea and emesis among patients with multiple myeloma and Lymphoma u...
- Hyperbaric oxygen improves enGraftment of ex-vivo expanded and gene transduced human CD34(+) cells in a murine model of umbilical cord blood transplantation.
- Delayed RSV diagnosis in a stem Cell transplant population due to mutations that result in negative polymerase chain reaction.
- Generating CK19-positive Cells with hair-like structures from Wharton's jelly mesenchymal stromal Cells.
- Prophylactic use of zoledronic acid to prevent early bone loss is safe and feasible in patients with Acute myeloid leukemia undergoing allogeneic stem cell transplanta...
- Alternative donor transplantation: results of parallel phase II trials using HLA-mismatched related bone marrow or unrelated umbilical cord blood Grafts.
- Skin Recurrence of Transformed Mycosis Fungoides Postumbilical Cord Blood Transplant despite Complete Donor Chimerism.
- Inflammatory response following neutrophil recovery postchemotherapy in Acute myeloid leukemia cases without evidence of infection: role of homing of neutrophils.
- BU, melphalan and thiotepa as a preparative regimen for auto-transplantation in Hodgkin''s Disease.
- Late-onset intestinal perforation in the setting of posttransplantation microangiopathy: a case report.
- Blastic plasmacytoid dendritic cell neoplasm should be treated with Acute leukemia type induction chemotherapy and allogeneic stem cell transplantation in first remiss...
- Low-dose cidofovir in the treatment of symptomatic BK virus infection in patients undergoing allogeneic hematopoietic stem Cell transplantation: a retrospective analys...
- A patient with facial and neck swelling, dyspnea, and dysphagia.
- Bilateral upper extremity thrombophlebitis related to intraVenous amiodarone: a case report.
- Serologically documented loracarbef (Lorabid)-induced immune thrombocytopenia.
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anemia
- Carcinoma in Situ
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
University of Kansas School of Medicine -
East Tennessee State University -
University of Jordan Faculty of Medicine
Hospital
-
The University of Kansas Hospital
Drug Facts
| NPI NUMBER | 1013018415 | |
| NPPES Provider LastName | ALJITAWI | |
| NPPES Provider FirstName | OMAR | |
| NPPES Provider ZIPCode | 66160 | |
| NPPES Provider State | KS | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 63.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1013018415 |
| Last Name Of The Provider | ALJITAWI |
| First Name Of The Provider | OMAR |
| View All |
Similar Doctors
|
|
Dr. Stephen K. Williamson, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Priyanka Sharma, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter J. Van Veldhuizen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leyla Shune, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prakash Neupane, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roberto R. Rodriguez, MD |
|
|
Dr. Nisreen A. Haideri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suman Kambhampati, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sunil Abhyankar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allan R. Fleming, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chao H. Huang, MD
This Doctor is OpenDoctor Recommended.
|